Florealis secures its second seed round financing

Florealis, a Startup Reykjavik company from the 2013 cohort, has secured its second round of seed financing of ISK 50 million (USD 395,000). The investor group behind the investment consists of experts from the pharmaceutical industry and angel investors. Previously, Florealis had secured another ISK 50 million in its first seed round.

Florealis develops high quality herbal medicine, aiming to be the leading provider of such products in the Nordics.  The management team behind Florealis con­sists of indi­vid­u­als with var­ied back­grounds who all share a com­mon pas­sion for increas­ing pro­fes­sion­al­ism and qual­ity within the herbal medicine indus­try.


 The team’s expe­ri­ence within the phar­ma­ceu­ti­cal and medical indus­try cov­ers most facets of the process of bringing product from the lab to the market.

Florealis intends to use the capital for further development of its growing range of products and strengthen the sales and distribution network.

On behalf of Startup Reykjavik, I congratulate the founders and the management team with this delightful milestone.

For those interested, please see Kjarninn’s video coverage of Florealis (then Herberia) since last year with Kolbrún Hrafnkelsdóttir, the CEO of the company. The video is in Icelandic.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s